DNMT3A and heart disorder: Since in murine models of cardiac disease Tet2- and Dnmt3A-loss of function activated the inflammasome complex [86] and promoted fibrosis development [95], it is conceivable that Dnmt3A or Tet2-CHIP-driver mutations contributed to the development of AVS.